Literature DB >> 23279932

Tubulin isoforms identified in the brain by MALDI in-source decay.

Rima Ait-Belkacem1, David Calligaris, Lyna Sellami, Claude Villard, Samuel Granjeaud, Thérèse Schembri, Caroline Berenguer, L'houcine Ouafik, Dominique Figarella-Branger, Olivier Chinot, Daniel Lafitte.   

Abstract

Identification of biomarkers is a major issue for enhancement of chemotherapies. The molecular characterization of tissues necessitates the identification of thousands of biomolecules each participating in physiopathological processes. MALDI in-source decay (ISD) fragmentation has already been proven to be effective for protein characterization. However, the difficulty to identify proteins from complex mixtures such as tissue sections can limit the applications of this technique. In this study, we evidenced that tubulin has an unusual fragmentation pathway in the MALDI source. This striking property allowed the detecting of several mouse brain tubulin isotypes simultaneously by simply using laser fragmentation. Tubulin isoforms are consistent markers of a bad prognosis of solid tumors and could be the target of targeted chemotherapies. Such a direct molecular printout of tubulin in tissues is a milestone that should be useful either at preclinical or clinical stage.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23279932     DOI: 10.1016/j.jprot.2012.11.026

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  4 in total

1.  Analysis of Flexibility of Proteins by means of Positive and Negative Ion MALDI In-Source Decay Mass Spectrometry.

Authors:  Ryunosuke Iimuro; Mitsuo Takayama
Journal:  Mass Spectrom (Tokyo)       Date:  2014-02-01

2.  Selective and nonselective cleavages in positive and negative CID of the fragments generated from in-source decay of intact proteins in MALDI-MS.

Authors:  Mitsuo Takayama; Sadanori Sekiya; Ryunosuke Iimuro; Shinichi Iwamoto; Koichi Tanaka
Journal:  J Am Soc Mass Spectrom       Date:  2013-10-18       Impact factor: 3.109

3.  Monitoring therapeutic monoclonal antibodies in brain tumor.

Authors:  Rima Ait-Belkacem; Caroline Berenguer; Claude Villard; L'Houcine Ouafik; Dominique Figarella-Branger; Alain Beck; Olivier Chinot; Daniel Lafitte
Journal:  MAbs       Date:  2014       Impact factor: 5.857

4.  In-Source Decay and Pseudo-MS3 of Peptide and Protein Ions Using Liquid AP-MALDI.

Authors:  Rima Ait-Belkacem; Marialaura Dilillo; Davide Pellegrini; Avinash Yadav; Erik L de Graaf; Liam A McDonnell
Journal:  J Am Soc Mass Spectrom       Date:  2016-10-17       Impact factor: 3.109

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.